{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-019713","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2023-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.321277+00:00","generated_at":"2026-06-07T14:49:54.035586+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Coherus CFO Stilwell resigns; EVP McMichael named Interim CFO","bullets":["McDavid Stilwell resigned as CFO and Principal Financial Officer, effective Dec 31, 2023, to pursue other opportunities.","Bryan McMichael appointed Interim CFO and Principal Financial Officer, effective Dec 8, 2023.","McMichael continues as EVP, Accounting, Corporate Controller and Principal Accounting Officer; previously at Gilead Sciences.","No compensatory changes or grants in connection with the interim appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-019713","json":"https://secwatch.observer/filing/0001558370-23-019713.json","markdown":"https://secwatch.observer/filing/0001558370-23-019713.md","text":"https://secwatch.observer/filing/0001558370-23-019713.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/chrs-20231209x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:49:54.035586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e4162d7e5","claim":"Bryan McMichael was appointed as Interim Chief Financial Officer and Principal Financial Officer at Coherus Oncology, Inc..","evidence_excerpt":"The Board of Directors of the Company appointed Bryan McMichael, age 45, to serve as the Company’s Interim Chief Financial Officer and Principal Financial Officer effective December 8, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer and Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e0a639c284","claim":"McDavid Stilwell resigned as Chief Financial Officer, Principal Financial Officer at Coherus Oncology, Inc..","evidence_excerpt":"McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer, Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}